Elevation of Receptor Tyrosine Kinase EphA2 Mediates Resistance to Trastuzumab Therapy

Cancer Research - United States
doi 10.1158/0008-5472.can-09-1845
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Claudin-4 Controls the Receptor Tyrosine Kinase EphA2 Pro-Oncogenic Switch Through ?-Catenin

Cell Communication and Signaling
BiochemistryCell BiologyMolecular Biology
2014English

A Conditional Transmembrane Peptide Inhibits Cell Migration by Activation of the EphA2 Receptor Tyrosine Kinase

Biophysical Journal
Biophysics
2019English

Bruton’s Tyrosine Kinase Mediates FcγRIIa/Toll-Like Receptor–4 Receptor Crosstalk in Human Neutrophils

American Journal of Respiratory Cell and Molecular Biology
Respiratory MedicinePulmonaryClinical BiochemistryCell BiologyMolecular Biology
2013English

Biological and Structural Characterization of Glycosylation on Ephrin-A1, a Preferred Ligand for EphA2 Receptor Tyrosine Kinase

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2013English

APOBEC3 Mediates Resistance to Oncolytic Viral Therapy

Molecular Therapy - Oncolytics
Cancer ResearchOncologyMolecular MedicinePharmacology
2018English

Personalized Therapy of Tyrosine Kinase Inhibitors

Japanese Journal of Clinical Pharmacology and Therapeutics
Pharmacology
2013English

Tight Junction Protein Junctional Adhesion Molecule-A Regulates the Expression of Receptor Tyrosine Kinase EPHA2 in Triple-Negative Breast Cancer Cells

Clinical Oncology and Research
2019English

Expression of T-Darpp Mediates Trastuzumab Resistance in Breast Cancer Cells

Clinical Cancer Research
Cancer ResearchOncology
2008English

Receptor Tyrosine Kinase (RTK); VEGF-A

Science-Business eXchange
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy